Comparison of biochemical parameters among DPP4 inhibitor users and other oral hypoglycaemic drug users: a cross-sectional study from Anuradhapura, Sri Lanka

BACKGROUND: Higher efficacy of incretin-based therapies for type 2 diabetes mellitus has been reported from Asia. Pancreatitis and hepatitis have also been suspected to occur due to dipeptidyl peptidase-4 inhibitor (DPP4I) treatment. The present study aims at comparing selected biochemical parameter...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathish, Devarajan, Jayasumana, Channa, Agampodi, Suneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343272/
https://www.ncbi.nlm.nih.gov/pubmed/30674350
http://dx.doi.org/10.1186/s41043-019-0160-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343272/
https://www.ncbi.nlm.nih.gov/pubmed/30674350
http://dx.doi.org/10.1186/s41043-019-0160-x

Ejemplares similares